American Society for Experimental Neurotherapeutics – ASENT 2019 Annual Meeting, 17 July, Maryland, USA

Kaufmann, W. E. Longitudinal 148-Week Extension Study Of Anavex®2-73 For The Treatment Of Alzheimer’s Disease Demonstrates Maintained Activities Of Daily Living Score (ADCS-ADL) And Reduced Cognitive Decline (MMSE) For Patient Cohort On Higher Drug Concentration And Conf. Am. Soc. Exp. Neurother. 2019 Annu. Meet. 17 (2019).